Sixteen Swiss hospitals take part in coronavirus global Solidarity trial
Some 1,000 patients in Switzerland are expected to participate in trials of experimental treatments for Covid-19 as part of the WHO global Solidarity trial.
Launched in March under the auspices of the World Health Organisation, the Solidarity trialExternal link aims to generate reliable data on the effectiveness and side effects of potential treatments.
While randomized clinical trials normally take years to design and conduct, the Solidarity trial is expected to reduce the time by 80% by enrolling patients in one single randomized trial. This will overcome the risk of multiple small trials not generating strong enough evidence.
The WHO has selected four therapies for testing based on laboratory, animal and clinical studies evidence of their potential to treat Covid-19. This includes remdesivir, chloroquine or hydroxychloroquine, lopinavir plus ritonavir, and interferon-beta. Novartis recently announced it was donating up to 130 million doses of the antimalarial drug hydroxychloroquine in part to advance clinical trials.
Switzerland is one of some 70 countries participating in the effort along with France, Spain, South Africa and Canada. The Swiss National Science Foundation (SNSF) has provided CHF1.6 million to the global trial and is working closely with the Federal Office of Public Health. Lausanne University Hospital CHUV is coordinating Switzerland’s participation in the tiral.
The sixteen hospital centres are the university hospitals of Lausanne, Geneva, Bern and Basel, the hospital networks of Valais and Neuchâtel, along with several cantonal hospitals. The hospitals are expected to recruit up to 1,000 patients to take part in the study according to a statementExternal link from CHUV.
The trial in Switzerland is expected to last from three months to one year but will depend in part on the evolution of the epidemic. The study may include up to 1,000 adult hospitalized patients who have not yet received treatment with Covid-19.
According to the WHOExternal link, patients diagnosed with COVID-19 and who have consented to be part of the study will be randomly selected to receive either local standard care alone or local standard care and one of a list of study drugs.
SNSF also announced that it has received 284 grant applicationsExternal link for its special call for coronavirus research issued in March. Funding decisions are expected to be communicated around mid-May 2020.
Swiss authorities announce cost-cutting in asylum sector
This content was published on
The government notably wants to improve integration into the labour force, particularly for people with protection status S.
Various leaders confirm participation at Ukraine peace conference
This content was published on
The presidents of Poland, Finland, and Latvia and the prime ministers of Spain and Belgium will be at the Swiss-hosted talks in mid-June.
This content was published on
In the winter season up to April 2024, railway and cable car operators ferried 3% more visitors compared to the previous winter, and 5% more than the five-year average.
Rhine flooding: Swiss to invest CHF1 billion with Austria
This content was published on
As part of an international agreement with Austria, the Swiss government wants to pump CHF1 billion ($1.1 billion) into flood protection measures along the Rhine over the next three decades.
Swiss government proposes CHF10 million UNRWA donation
This content was published on
After months of debate, Switzerland plans to give CHF10 million ($11 million) to the UN agency this year, rather than the CHF20 million initially foreseen.
Swiss study: insects mainly migrate at midday and dusk
This content was published on
A study led by the Swiss Ornithological Institute in canton Lucerne is helping to better understand the movement patterns of migratory insects.
Red Cross: 22 staff killed in Middle East since October
This content was published on
The Red Cross and Red Crescent network in Gaza and Israel has lost 22 staff members since last October, the Swiss Red Cross (SRC) said on Wednesday.
Dortmund’s Kobel is first Swiss goalie in Champions League final
This content was published on
Borussia Dortmund’s Gregor Kobel has achieved history by becoming the first Swiss goalkeeper to reach a Champion’s League final.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
WHO and Roche launch trials of potential coronavirus treatments
This content was published on
Roche is launching a clinical trial of a potential new Covid-19 drug, adding to rapidly growing investments in combating coronavirus.
Balancing hope and science in the search for a coronavirus cure
This content was published on
The debate surrounding the antimalarial drug hydroxychloroquine epitomises companies' balancing act between hope and scientific realities.
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.